Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multitarget Therapy for Idiopathic Membranous Nephropathy
NCT04424862Phase 4Completed
- Sponsor
- Beijing Friendship Hospital
- Start
- Jun 2020
- Primary completion
- Feb 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine, mycophenolate mofetil in idiopathic membranous nephropathy (IMN), sponsored by Beijing Friendship Hospital. Started Jun 2020; status: completed.
02
Drugs
cyclosporinemycophenolate mofetil
03
Conditions
idiopathic membranous nephropathy (IMN)
Beyond the preview
Go deeper on NCT04424862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04424862.